Spurges are referred to as spotted spurge, creeping spurge, or prostrate spurge, and these unwanted plants can spread rapidly ...

Prostate cancer starts when cells in the prostate gland grow out of control. Those cells can spread to other parts of the body and affect healthy tissue. This can happen for several reasons. When ...

What Is the Gleason Grading System? Many people with prostates have cancer cells in their prostate that never grow into a tumor or spread. If your pathologist finds cancer cells in your biopsy ...

Maintaining prostate health is vital for overall wellbeing in men. As men age, they become increasingly prone to prostate-related issues. Prostate supplements are designed to promote prostate ...

Charities and doctors have welcomed the King going public about needing treatment for an enlarged prostate. It could encourage men with similar symptoms to get a check-up, they say. An enlarged ...

NOBODY WANTS TO find out they have prostate cancer. Yet the earlier it's detected, the better. The cancer is very treatable when it's discovered early; you’ll have the most treatment options ...

A new treatment for non-cancerous enlargement of the prostate, a very common condition in older men, has been recommended for use by the NHS. It's called prostate artery embolisation. And it ...

Prostate cancer is a type of malignancy that arises in the prostate gland. Prostate cancer tends to develop in older men, aged 50 and over. In many cases prostate cancer develops slowly, although ...

Research into magnetic resonance imaging (MRI) for prostate cancer screening and diagnosis has been ongoing for more than a decade. Initially, MRI was thought to be important for achieving two goals.

King Charles has had his treatment for an enlarged prostate, after being admitted to hospital on Friday morning. Queen Camilla said the King is "doing well". He is expected to spend at least one ...

Data on the efficacy and safety of screening for prostate cancer with magnetic resonance imaging (MRI) are needed from studies of follow-up screening. In a population-based trial that started in ...